SCHOTT Pharma AG & Co. KGaA

Research SCHOTT Pharma AG & Co. KGaA (1SXP) on Bullrun: market cap EUR 3.73B, P/E 27.5, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker1SXP
ExchangeXETRA
CountryGermany
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencyEUR
Market capEUR 3.73B
P/E27.5
Dividend yield0.8%
Financial periodQ1 2026
RevenueEUR 247.88M
Net incomeEUR 31.01M
Free cash flowEUR 65.06M
Gross margin30.3%

Valuation Snapshot

latest market cap is EUR 3.73B; P/E is 27.5; dividend yield is 0.8%.

Peer valuation comparison

Latest P/E is 27.5x versus a Healthcare sector median of 24.61x (11.8% above).

Latest dividend yield is 0.75% versus a Healthcare sector median of 1.84% (59.2% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	EUR 996.56M	EUR 150.74M	EUR 11.18M	33.7%	n/a	EUR 24.59M	EUR 83.01M	EUR 930.17M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-05	EUR 3.73B	27.5	0.7%	0.18

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.18 EUR, yield 0.8%.

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments;

Related stock research

Germany stocks Germany Healthcare stocks A-Z stock index

Other Healthcare stocks

Carl Zeiss Meditec AG (AFX) Bio-Gate AG (BIG.DE) GERRESHEIMER (GXI) Anbio Biotechnology - Class A (NNNN) Ottobock SE & Co. KGaA (OBCK) Paul Hartmann AG (PHH2.F) SARTORIUS (UNSP.ADS)/1/5 (SRT0) Sartorius Aktiengesellschaft (SRT3) TME PHARM.CONF.IPO EO 1- (0N6A) Cannovum Cannabis AG (27N0.DE) MAINZ BIOMED B.V. EO 1 (4TO) Novogenia AG (7V0.DE)

Frequently asked questions

What is SCHOTT Pharma AG & Co. KGaA's market cap?

SCHOTT Pharma AG & Co. KGaA's market capitalization is EUR 3.73B.

What is SCHOTT Pharma AG & Co. KGaA's P/E ratio?

SCHOTT Pharma AG & Co. KGaA's price-to-earnings (P/E) ratio is 27.5.

Does SCHOTT Pharma AG & Co. KGaA pay a dividend?

SCHOTT Pharma AG & Co. KGaA has a dividend yield of 0.8%.

What does SCHOTT Pharma AG & Co. KGaA do?

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.